An international consortium found a remarkable global spread of strains of a multi-resistant bacterium that can cause severe infections – Stenotrophomonas maltophilia. The study, published under the
MHH professor and DZIF scientist Thomas Pietschmann leads the German part of an international consortium of scientists. This research network is searching for substances that act against SARS-CoV-2 in
Over the past 20 years, coronaviruses have been responsible for large outbreaks, resulting in severe respiratory illness and a number of deaths. These include the SARS coronavirus outbreak in 2002
Alongside developing vaccines, scientists at the German Center for Infection Research (DZIF) are working at high speed to develop new drugs to improve the treatment of COVID-19 patients. A DZIF
In the global fight against the new coronavirus, an increasing number of clinical trials are being conducted on drugs to fight the virus in many countries of the world including Germany. In order to
A top global priority is to find agents that can stop the severe course of COVID-19 infection and consequently increase the chances of patient survival as rapidly as possible. Specific tests have
A group of scientists, physicians, funders, and policy makers from over 70 institutions from over 30 countries have launched an international coalition to respond to COVID-19 in resource-poor settings
Research has been called to develop drugs, vaccines and testing methods as quickly as possible to fight the SARS-coronavirus-2. A fast-track procedure has made additional funding available to
The reserve antibiotic daptomycin is used primarily when conventional drugs fail due to resistant bacteria. Although the antibiotic was developed around 30 years ago, its exact mode of action was
The new coronavirusSARS-CoV-2 has been identified as the pathogen behind the COVID-19 pandemic. The virus contains a main protease termed Mpro (or also termed 3CLpro), which is involved in the
